Psychedelic medicine pioneer exits MDMA biotech after regulatory blow
Psychedelic medicine pioneer, Rick Doblin, has left the MDMA biotech company, MAPS, following a regulatory setback. This decision comes after ...
Psychedelic medicine pioneer, Rick Doblin, has left the MDMA biotech company, MAPS, following a regulatory setback. This decision comes after ...
In a groundbreaking decision, a Dutch panel has recommended the use of MDMA, also known as ecstasy, for the treatment ...
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.
Copyright © 2024 News Wave
News Wave is not responsible for the content of external sites.